ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

The marijuana industry is in the midst of a classic bubble, reminiscent of the dot.com boom (and bust) of the late 1990s. To be sure, “canna-business” represents one of the greatest investment opportunities you’ll see in your lifetime and certain marijuana stocks offer the potential for exponential gains. However, investors… Read More

Medicine Man Technologies (OTC: MDCL) belongs to a fast-growing marijuana industry niche: consulting and infrastructure services. Medicine Man is not a marijuana producer. The chattering class on Wall Street is infatuated with cannabis stocks. But with Medicine Man, we must raise several caveats. Not only is this a marijuana play,… Read More

This article will examine a popular topic for many investors: the cheapest blue chip stocks. Blue chips stocks are often considered core holdings in long-term diversified portfolios. The general idea is that these are legacy companies that are “quality investments”, leaders in their field, and have massive market capitalizations. Most… Read More

Today we’ll look at one of the most vital sectors in the global economy: the cheapest energy stocks in the stock market. Energy stocks are a mandatory holding in any serious portfolio. Energy stocks are something I consider “must-owns” because they represent companies that have a central part in every… Read More

Tech stocks are always hot, so today we’ll look for the cheapest tech stocks in the stock market. By “cheapest”, I refer to relative valuation. We also need to be circumspect, because the cheapest tech stocks may be cheap for good reasons. We want tech stocks that are not selling… Read More

Biotech stocks can offer growth to a portfolio, so today I’ll look for the cheapest biotech stocks in the stock market. By “cheapest”, we want stocks that are selling at a discount to intrinsic value. That can be difficult to determine since biotech stocks are either well-established and selling at… Read More